Egypt Emerges as Wind and Solar Hotspot
Feb 03, 2016 09:00 am UTC| Business
LONDON, Feb. 03, 2016 -- FTI Consulting, Inc. (NYSE:FCN), the global business advisory firm dedicated to helping organisations protect and enhance their enterprise value, today announced the release of FTI...
Feb 03, 2016 08:49 am UTC| Business
Albany, NY, Feb. 03, 2016 -- According to a new market report published by Transparency Market Research “Lateral Flow Diagnostic Tests Market: APAC Industry Analysis, Size, Share, Growth Trends and Forecast, 2015 -...
Isostearic Acid Market Is Expected To Reach USD 447.9 Million By 2020 : Radiant Insights,Inc
Feb 03, 2016 06:50 am UTC| Business
San Francisco, Feb. 03, 2016 -- Global Isostearic Acid Market is expected to reach USD 447.9 million by 2020. Increasing personal care products demand particularly in Asia Pacific and Latin America is expected to drive...
Dimer Acid Market Size To Reach $1.90 Billion By 2020 : Radiant Insights,Inc
Feb 03, 2016 06:41 am UTC| Business
San Francisco, Feb. 03, 2016 -- The global Dimer Acid Market is expected to reach USD 1.90 billion by 2020. Increasing polyamide resins demand on account of high construction spending in Brazil, China, India and Mexico...
CGG: Awarded Survey Extension Offshore Colombia
Feb 03, 2016 06:37 am UTC| Business
PARIS, Feb. 3, 2016 -- CGG announced today that it has been awarded an extension to a major 3D seismic survey it successfully completed on the Caribbean coast offshore Colombia in late 2015. The new survey follows on...
BOURBON: Annual & 4th Quarter 2015 Revenues
Feb 03, 2016 06:13 am UTC| Business
Adjusted annual revenues increased 1.1% to €1,437 million at current rates, remained resilient during the prolonged oil industry downturn PARIS, Feb. 3, 2016 -- Regionally, adjusted revenues in 2015 in...
Celyad Appoints Dr. Richard Mountfield as Vice-President of Global Regulatory Affairs
Feb 03, 2016 06:00 am UTC| Business
MONT-SAINT-GUIBERT, Belgium, Feb. 03, 2016 -- Celyad (Euronext Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a leader in the discovery and development of engineered cell therapies, with clinical programs in cardiovascular...